TOETVA中手侧匹配策略的可行性与手术结局:学习曲线与倾向性评分匹配队列分析
本研究为单中心、单术者回顾性队列,纳入2016年8月至2020年8月连续单侧TOETVA病例,按非优势手-非优势侧(NDH-TOETVA,左手左叶)与优势手-优势侧(DH-TOETVA,右手右叶)分组,用累积和(CUSUM)将手术时间划分为三个阶段,并在第三阶段经1:1倾向性评分匹配(PSM)比较两组结局。匹配后共分析176例(NDH 88例,DH 88例),基线均衡,两组在手术时间、估计出血量、中央区淋巴结清扫数目/阳性数、住院时间、术后引流及并发症方面均无显著差异(P > 0.05)。结论认为手侧匹配策略在TOETVA中可行,手术结局相当。
要点
- CUSUM界定NDH-TOETVA掌握阶段为≥38例,DH-TOETVA为≥55例。
- 第三阶段PSM后NDH与DH各88例,基线特征均衡。
- 两组手术时间、出血、淋巴结、住院、引流及并发症均无显著差异(P > 0.05)。
核心结论
- 手侧匹配策略在TOETVA中可行,非优势手操作非优势侧与常规优势手操作优势侧的手术结局相当。
研究设计与样本
- 单中心、单术者回顾性队列,纳入2016年8月至2020年8月连续单侧TOETVA病例,按NDH-TOETVA(左手左叶)或DH-TOETVA(右手右叶)分组。
- 采用累积和(CUSUM)将手术时间划分为Phase I(初始)、Phase II(适应)、Phase III(掌握)三个阶段。
- 在Phase III经1:1倾向性评分匹配(PSM)后比较两组结局,匹配后共分析176例(NDH 88例,DH 88例)。
主要发现
- CUSUM识别阶段边界:DH-TOETVA Phase I为第1-13例,Phase II为第14-54例,Phase III为≥55例;NDH-TOETVA Phase I为第1-17例,Phase II为第18-37例,Phase III为≥38例。
- PSM后基线特征均衡。
- NDH与DH在手术时间、估计出血量、中央区淋巴结清扫数目/阳性数、住院时间、术后引流及并发症方面均无显著差异(P > 0.05)。
关键数值与推荐
- Phase III匹配后NDH 88例与DH 88例,各结局比较P > 0.05。
- CUSUM阶段划分:DH-TOETVA Phase I 1-13例、Phase II 14-54例、Phase III ≥55例;NDH-TOETVA Phase I 1-17例、Phase II 18-37例、Phase III ≥38例。
临床怎么用
- 可将手侧匹配策略及双手训练纳入TOETVA标准化实践,并以分阶段客观评估推进。
局限性
- 单中心、单术者回顾性队列设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To address the lack of guidance for operating the non-dominant side in TOETVA by assessing whether non-dominant-hand TOETVA on the non-dominant side (left hand-left lobe) is a feasible strategy with similar surgical outcomes compared with the conventional dominant-hand approach (right hand-right lobe). METHODS: This is a single-center, single-surgeon retrospective cohort. Consecutive unilateral TOETVA cases (August 2016-August 2020) were included. Patients were grouped as NDH-TOETVA (left hand on the left lobe) or DH-TOETVA (right hand on the right lobe). Learning curves were segmented using cumulative sum (CUSUM) of operative time into Phase I (initial), Phase II (adaptation), and Phase III (mastery). Phase III outcomes were compared after 1:1 propensity score matching (PSM) on key covariates. RESULTS: CUSUM identified distinct phase boundaries: DH-TOETVA Phase I cases 1-13, Phase II 14-54, Phase III ≥ 55; NDH-TOETVA Phase I 1-17, Phase II 18-37, and Phase III ≥ 38. After PSM in Phase III, 176 patients were analyzed (NDH 88 cases, DH 88 cases). Post-match baseline characteristics were balanced. There were no significant differences between NDH and DH in operative time, estimated blood loss, central neck lymph nodes retrieved/positive, length of stay, postoperative drainage, and complications (P > 0.05). CONCLUSIONS: Hand-side matching is a feasible strategy with compared surgical outcomes in TOETVA. Findings support incorporating this strategy and bilateral-hand training into standardized practice with phase-based, objective assessment. TRIAL REGISTRATION NUMBER: Chinese Clinical Trial Registry (UIN: ChiCTR2500097005, https://www.chictr.org.cn ), 2025.2.11.
引用
- Wen X, Li W, Zhou S, et al. Hand-side matching in TOETVA: assessing feasibility and surgical outcomes through learning curve and propensity score-matched cohorts. Surg Endosc. 2026. PMID: 42443685. doi:10.1007/s00464-026-13104-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。